Literature DB >> 26953225

GABAA receptor cysteinyl mutants and the ginkgo terpenoid lactones bilobalide and ginkgolides.

Chiu Chin Ng1, Rujee K Duke1, Tina Hinton1, Graham A R Johnston2.   

Abstract

The terpenoid lactones from Ginkgo biloba, bilobalide and ginkgolides, have been shown to act as negative modulators at α1β2γ2L GABAA receptors. They have structural features similar to those of the chloride channel blocker picrotoxinin. Unlike picrotoxinin, however they are not known to produce convulsant effects. Using two-electrode voltage clamp electrophysiology, this study compared the effect of mutation of 2', 6' and 15' pore facing M2 domain residues to cysteine on the action of picrotoxinin, bilobalide and ginkgolides at α1β2γ2L GABAA receptors expressed in Xenopus oocytes. Picrotoxinin was affected by mutation differently from the ginkgo terpenoid lactones. Although some of these compounds were affected by the mutation at same position and/or subunit, the changes in their potency were found to be dissimilar. The results suggest that the intracellular pore binding site for picrotoxinin, bilobalide, ginkgolide A, ginkgolide B and ginkgolide C is comprised of 2'β-6'β6'γ, 2'α2'β-6'α6'β, 2'α2'β2'γ-6'β6'γ, 2'α, 2'β2'γ-6'β and 2'α2'β, respectively. Unlike bilobalide and ginkgolides, the inhibitory action of picrotoxinin was not affected by mutations at 15' position. It is proposed that 15'α15'β, 15'β, 15'α15'β and 15'α15'β15'γ forms an extracellular pore binding site for bilobalide, ginkgolide A, ginkgolide B and ginkgolide C, respectively. The lack of convulsant effects of bilobalide, and ginkgolide A and B may be associated in part with their different binding locations within the chloride channel.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bilobalide; Bilobalide (PubChem CID: 73581); GABA (PubChem CID: 119174); GABA(A) receptor; Ginkgolide A (PubChem CID: 9909368); Ginkgolide B (PubChem CID: 6324617); Ginkgolide C (PubChem CID: 161120); Ginkgolides; MTSEA; Picrotin (PubMed CID: 442291); Picrotoxinin; Picrotoxinin (PubChem CID: 442292); pCMBS; pCMBS (PubChem CID: 11136) MTSEA (PubChem CID: 57363907)

Mesh:

Substances:

Year:  2016        PMID: 26953225     DOI: 10.1016/j.ejphar.2016.03.007

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo.

Authors:  Qiu Liu; Zhiquan Jin; Zhiliang Xu; Hao Yang; Liang Li; Guiping Li; Fang Li; Shaoli Gu; Shaobo Zong; Jun Zhou; Liang Cao; Zhenzhong Wang; Wei Xiao
Journal:  Cell Stress Chaperones       Date:  2019-02-27       Impact factor: 3.667

2.  Synthetic, Mechanistic, and Biological Interrogation of Ginkgo biloba Chemical Space En Route to (-)-Bilobalide.

Authors:  Robert M Demoret; Meghan A Baker; Masaki Ohtawa; Shuming Chen; Ching Ching Lam; Sophia Khom; Marisa Roberto; Stefano Forli; Kendall N Houk; Ryan A Shenvi
Journal:  J Am Chem Soc       Date:  2020-10-16       Impact factor: 15.419

3.  Ginkgolide A Ameliorates LPS-Induced Inflammatory Responses In Vitro and In Vivo.

Authors:  Yan Li; Yannan Wu; Xinlei Yao; Fang Hao; Chunlei Yu; Yongli Bao; Yin Wu; Zhenbo Song; Ying Sun; Lihua Zheng; Guannan Wang; Yanxin Huang; Luguo Sun; Yuxin Li
Journal:  Int J Mol Sci       Date:  2017-04-10       Impact factor: 5.923

4.  Identification of the Functional Binding Site for the Convulsant Tetramethylenedisulfotetramine in the Pore of the α 2 β 3 γ 2 GABAA Receptor.

Authors:  Brandon Pressly; Ruth D Lee; Bogdan Barnych; Bruce D Hammock; Heike Wulff
Journal:  Mol Pharmacol       Date:  2020-10-27       Impact factor: 4.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.